Rigel Pharmaceuticals, Inc. (RIGL) Profit Margins
Over the twelve months to 2026-06-30, Rigel Pharmaceuticals, Inc. (RIGL) had gross margin 91.4%, operating margin 31.5%, net margin 116.3%, free cash flow margin 28.7%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RIGLRigel Pharmaceuticals, Inc.Follow RIGL — free
—
Price chart with a free account
- Market cap
- 899.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 99.4% | 98.5% | 99.2% | 99.3% | 98.5% | 93.9% | 89.6% | 93.3% | 91.4% | |
| Operating margin | -163.3% | -116.5% | -26.7% | -8.4% | -46.2% | -17.5% | 13.5% | 42.6% | 31.5% | |
| Net margin | -158.3% | -112.8% | -27.4% | -12.0% | -48.7% | -21.5% | 9.8% | 124.7% | 116.3% | |
| FCF margin | -134.7% | -72.5% | -49.2% | 3.5% | -61.7% | -4.9% | 17.5% | 25.7% | 28.7% |
USD millions · SEC XBRL
Rigel Pharmaceuticals, Inc. — questions
- What is Rigel Pharmaceuticals, Inc.'s gross margin?
- 91.4% over the twelve months to 2026-06-30.
- What is Rigel Pharmaceuticals, Inc.'s operating margin?
- 31.5% over the twelve months to 2026-06-30.
- What is Rigel Pharmaceuticals, Inc.'s net profit margin?
- 116.3% over the twelve months to 2026-06-30.
Every figure on this page comes from Rigel Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.